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Abstract 
Pregnancy Body Mass Index and its Relationship with Maternal and Fetal Health 
Outcomes in Rural Appalachia 
 
Lauren Angela Winter, MS 
 
University of Pittsburgh, 2020 
 
 
Abstract 
 
Increased weight gain or obesity in pregnancy has been identified as a risk factor for 
multiple adverse maternal and child health outcomes that are of large public health concern. 
Maternal obesity can also complicate obstetric care by preventing identification of ultrasound 
markers or decreasing available fetal cell-free DNA fraction for routine genetics studies.  
The study analyzes the pregnancy, birth, and early childhood data from 995 mother-child 
pairs in the COHRA2 study to assess maternal body mass index and its associations with 
pregnancy risk factors and childhood health outcomes in this population. 
We found that women and children in our sample were similar to the United States 
population in the prevalence of obesity (36%) during pregnancy and had an increased prevalence 
of gestational diabetes mellitus (8%) as a pregnancy complication. We observed a low overall 
frequency of congenital birth defects (1.9%), and no significant difference in frequency between 
infants born to obese versus nonobese mothers. Additionally, we were able to replicate findings 
from studies in other populations, observing that there was a higher rate of Cesarean delivery for 
women who gave birth to macrosomic (>4000 grams) infants (p=0.003), and that children who 
were macrosomic at birth were more likely to be obese in childhood and were younger at the time 
of their first tooth eruption, illustrating that obesity is a risk factor for adverse childhood outcomes 
even past the neonatal period.  Lastly, we found significant differences between the Pittsburgh and 
West Virginia participants in our study, demonstrating that urban and rural populations have 
  v 
significant sociodemographic differences (particularly in rates of obesity (p=2.19x10-5), frequency 
of Cesarean delivery (p=0.005), and time to first tooth eruption (p<0.0001) that are important 
considerations when developing public health interventions.  
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1.0 Introduction 
Fetal development is impacted by complex interactions between genetic predispositions 
and exposures from nutrition, maternal health conditions, and maternal lifestyle influences 
(Institute of Medicine (US) Committee on Nutritional Status During Pregnancy and Lactation, 
1990; Julihn et al., 2009).  The prevalence of overweight and obesity are rising worldwide 
(Rahman et al., 2015; Sommer et al., 2014; Wang et al., 2019) and maternal overweight and obesity 
pre-pregnancy or during pregnancy raise concern for adverse maternal and fetal outcomes.  A 
growing body of evidence suggests that obese women who have excessive weight gain during 
pregnancy experience the highest risk for adverse pregnancy outcomes (Durie et al., 2011; Ferrari 
& Siega-Riz, 2013). Figure 1 demonstrates the breadth of adverse outcomes that have been 
associated with maternal overweight, obesity, and/or increased weight gain during pregnancy.  
 
Figure 1: Maternal Overweight and Obesity Associations Cited in Literature 
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Past the neonatal period, few studies to date have analyzed the long-term consequences 
associated with an increased pregnancy BMI. One reason may be the complex relationship of 
maternal weight gain with other pregnancy factors, socioeconomic factors, nutritional status and 
profile, and/or chronic maternal disease. Obesity risk genes have also been shown to be associated 
with gestational weight gain (Beysel et al., 2019; Groth & Morrison-Beedy, 2015; Lawlor et al., 
2011; Martins et al., 2016; Meng et al., 2018; Sharp et al., 2017).   
Due to the interplay of these various factors and their downstream effects on children’s 
health and behaviors, it is of interest to know if there is any relationship between maternal BMI 
and health outcomes in their children past the neonatal period. Socioeconomic and geographic 
influence are important when considering a public health intervention, and differences that may 
exist between groups from different regions of the world should be considered.  
Genetic counselors interact with pregnant women for a variety of indications and are an 
integral part of many expectant mothers’ obstetric care. As a resource for exploring the risks and 
benefits of genetic tests for a variety of indications, genetic counselors also counsel about risks for 
congenital birth defects – some of which, such as neural tube defects, omphalocele, and congenital 
heart defects, have been shown to be associated with higher maternal BMI (Racusin et al., 2012) 
in the absence of genetic etiologies.  Genetic counselors also often discuss with women how the 
results of Noninvasive Prenatal Testing (NIPT) can be impacted by increased maternal weight. 
However, it is prudent to consider maternal weight as more than just a modifier on test outcome, 
and that an overweight or obese woman may have specialized pregnancy considerations for which 
she should be assessed (Beysel et al., 2019; Bianchi et al., 2018; Sharp et al., 2017). There is 
evidence that detection methods for fetal anomalies are more limited by maternal obesity (Racusin 
et al., 2012), owing to the inability to visualize some anatomical structures (both fetal and 
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maternal) because of the maternal body fat.  This limitation to screening is placing these women 
at a higher risk for a complicated pregnancy that is mismanaged due to lack of detection of fetal 
malformation.  
The goal of the current study is to investigate the role of maternal BMI on outcomes in 
children, specifically on adverse health outcomes that are preventable. Children aged 2-5 years 
living in Appalachia have a childhood caries (cavities) rate that is 144% of the national average  
(Wen et al., 2017), taken from data gathered from the Center for Disease Control’s 1999-2004 
National Health and Nutrition Examination Survey (National Institute of Dental and Craniofacial 
Research, 2018).  “Implementing preventative measures against childhood diseases, such as early 
childhood caries, caries and other metabolic conditions (Carolina Un Lam et al., 2016)” has been 
cited as support for investigating the complex relationship between prenatal risk factors and 
eruption timing of the first tooth.  This study of obesity will be a novel investigation into the role 
of a global health problem’s impact on a population that is vulnerable to phenomena that perpetuate 
health disparities. With this study, we aim to contribute further evidence in favor of prenatal 
healthcare providers – including genetic counselors – and public health professionals supporting 
healthy weight as a risk-reducing intervention.  
1.1 Factors Affecting Rural Appalachia 
Children living in Appalachia demonstrate poorer oral health and elevated rates of caries 
earlier in life compared with the national averages (Neiswanger et al., 2015). Research from the 
University of Pittsburgh’s Center for Oral Health Research in Appalachia (COHRA) has 
previously illustrated the various unique demographic characteristics of the population in Rural 
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Appalachia. Appalachia is a region of the eastern United States, covering parts of northern 
Mississippi, Alabama, Georgia, and reaching up to western New York – roughly corresponding to 
the Appalachian mountain range. Due to the mountainous terrain, the region is largely rural, and 
its populations have been historically geographically isolated. Individuals living in Appalachia 
have historically experienced higher levels of poverty and food insecurity (Neiswanger et al., 
2015).  
Women enrolled in the “Factors Contributing to Oral Health Disparities in Appalachia” 
study (COHRA2 and COHRA Smile) live in West Virginia and Western Pennsylvania and 
delivered a singleton pregnancy at 36 weeks or more between 2012 and 2019. They identify as 
either White (Non-Hispanic or Latino) or African American. Women are English speaking and 
non-immunocompromised.  
We have also previously reported significant differences within our study population 
between the populations from Pittsburgh and West Virginia. In 2015, the 727 participants in 
COHRA2 were assessed for demographic characteristics via telephone and in-person interview as 
part of their study visit. The following table (Table 1) is adapted from Neiswanger et al. (2015) 
and shows the areas on the questionnaires where women in Pittsburgh and West Virginia 
significantly differed in their responses. These include personal, household, and social behavioral 
demographics. Pregnant participants from Pittsburgh had more education, higher income, greater 
employment, more dental insurance and private medical insurance, self-reported better health, had 
fewer children in the household, less food anxiety, and drank more and smoked less than 
participants in West Virginia (Neiswanger et al., 2015).  
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Table 1: Demographic Differences in the COHRA2 Study 
Demographic differences between Pittsburgh and West Virginia residents enrolled in the 
COHRA2 study. Adapted from Neiswanger et al. 2015 
Personal Demographics Household Demographics Social Behavior 
Education 
Level 
P <0.00001 Additional people 
in household 
P=0.002 Drank 
alcohol any 
time up until 
2nd trimester 
P <0.00001 
Ever employed P = 0.0008 Additional Children P=0.0002 Smoked 3 
months prior 
to pregnancy 
through 2nd 
trimester 
P=0.02 
Current 
employment 
status 
P <0.00001 Worried food 
would run out in 
the past year 
P=0.001   
Type of 
Medical 
Insurance 
P<0.00001 Food did run out in 
the past year 
P=0.001   
Having Dental 
Insurance 
P<0.00001 Household Income P<0.00001   
Self-report 
general health 
P=0.002     
 
The COHRA study population represents a unique subset of the United States population. 
For the aforementioned reasons, the COHRA studies aim to identify genetic, lifestyle, metabolic, 
and socioeconomic factors that contribute to the oral health in this population. The robust data set 
gathered by COHRA investigators also contributes information about maternal-fetal wellness, due 
to the longitudinal nature of the study. There may be overlap in the risk factors that contribute to 
healthy pregnancy outcomes and oral health disparities; and there is reason to consider that this 
population may also be at risk for adverse neonatal outcomes.  
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2.0 Literature Review 
2.1 Pregnancy BMI 
While the highest proportion of obesity in women worldwide is in those 55 and older, 
trends in adult age-standardized obesity prevalence show that more rapid weight gains occur 
between ages 20-40 years (Ng et al., 2014).  This age range encompasses the majority of women 
of child-bearing age. It is estimated that 33% of women in the United States are obese, and that 
the number of obese pregnancies is 1.1 million, representing 34.9% of pregnant women (Chen et 
al., 2018).   
Maternal body mass index (BMI) during pregnancy is a known risk factor for multiple 
adverse outcomes for both the mother and the developing fetus (Chen et al., 2018) and is a growing 
public health problem worldwide (Beysel et al., 2019; Bianchi et al., 2018).  The exact biological 
mechanism for how increased BMI has an adverse effect on a pregnancy is not known. One 
hypothesis is that obesity increases adipocyte number or pelvic soft tissue mass. Adipocyte 
abundancy may be a cause of excessive inflammatory responses, influencing the development of 
gestational diabetes; while pelvic soft tissue could cause narrowing of the birth canal and warrant 
cesarean delivery (Rahman et al., 2015).  Conversely, negative control studies have investigated 
the postnatal environmental and genetic confounders in the relationships between maternal and 
paternal adiposity and child outcomes; these studies have found only limited support for the effects 
of maternal adiposity on offspring adiposity, and it is worth investigating whether maternal 
adiposity has other, intrauterine effects on the developing fetus (Sharp et al., 2017).  
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Overall, higher body mass index during pregnancy is considered a risk factor for both 
mother and fetus. We will briefly highlight research on both excess weight gain during pregnancy 
and excess weight in general while pregnant. Both states are risk factors for adverse health 
outcomes.  
2.2 Weight Gain During Pregnancy 
Fetal growth accounts for approximately 25% of all weight gain during pregnancy, while 
expansion of maternal tissues (uterine and mammary tissue mass, blood volume, extracellular 
fluid, and fat stores) accounts for approximately two-thirds of the total gain (Institute of Medicine 
(US) Committee on Nutritional Status During Pregnancy and Lactation, 1990).  High gestational 
weight gain has been associated with long-term maternal weight retention, risk for type II diabetes, 
and other obesity-related disorders for mothers later in life (Hales, 2017; Mannan et al., 2013; 
Nehring et al., 2013; Sharp et al., 2017; Walker et al., 2011).  
Goldstein et al. completed a systematic review and meta-analysis of over 1 million 
pregnant women which found that 47% had gestational weight gain greater than Institute of 
Medicine (IOM) recommendations and 23% had gestational weight gain less than IOM 
recommendation. Gestational weight gain that is greater than guideline recommendations, 
compared with weight gain within recommended levels, was associated with higher risk of adverse 
maternal and infant outcomes. Table 2 includes the IOM’s 2009 guidelines for healthy gestational 
weight gain based on World Health Organization (WHO) categories of BMI (Goldstein et al., 
2017).   
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Table 2: IOM Gestational Weight Gain Guidelines 
Gestational Weight Gain Guidelines 
Category WHO BMI Category (%) IOM Suggested Gestational 
Weight Gain (kg) 
Underweight <18.5 12.5-18 
Normal 18.5-24.9 11.5-16 
Overweight 25-29.9 7-11 
Obese 30 or greater 5-9 
 
The 2009 IOM guidelines also included recommended rates of weight gain per week for 
the second and third trimesters, defined by weight category: 1-1.3 pounds for underweight, 0.8-1 
pound for normal weight, 0.5-0.7 pound for overweight, and 0.4-0.6 pound for obese (Institute of 
Medicine (US) and National Research Council (US) Committee to Reexamine IOM Pregnancy 
Weight Guidelines, 2009).  Limited weight gain or even net weight loss have not been shown to 
have an effect on small-for-gestational age neonates in obese women and this change may even 
improve perinatal outcomes (Durie et al., 2011). In the Pregnancy, Infection, and Nutrition (PIN) 
Study at the University of North Carolina, 78% of women reported gaining weight outside the 
current provider recommendations (Ferrari & Siega-Riz, 2013).   
A 2004 study by Kabiru et al. followed 5131 women during singleton pregnancies. The 
normal weight women who had an increase in BMI category between the start of pregnancy and 
the end had an associated higher rate of gestational diabetes, failed induction, lacerations, and 
postpartum infection. In overweight women, increased rates of preeclampsia and operative vaginal 
deliveries were observed. Obese women had higher rates of chorioamnionitis (an infection usually 
associated with prolonged labor), failed induction, and Cesarean deliveries (Kabiru & Raynor, 
2004).  
Durie et al. studied a large cohort of women to analyze the effects of excessive second- and 
third-trimester weight gain on pregnancy outcomes. They showed that in their cohort of women 
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with singleton pregnancies, there was an increased odds of labor induction and admission to the 
neonatal intensive care unit if women were of normal weight and had excessive rates of weight 
gain (Durie et al., 2011).  Additionally, women in all weight classes who had excessive rates of 
second-or third-trimester weight gain had an increased odds of having a cesarean delivery (Durie 
et al., 2011).   
Usta et al. found that 366 newborns, representing 8.6% of newborns in their study were 
macrosomic at birth (weighing at least 4000 grams). In the macrosomic vs. non-macrosomic 
infants, maternal age, parity, pre-pregnancy BMI and gestational weight gain were higher in the 
group of mothers who had macrosomic infants (Usta et al., 2017).  Mothers had cesarean deliveries 
more often when fetuses were macrosomic, and male fetuses were more likely to be macrosomic 
(Usta et al., 2017).   
2.3 Overweight or Obesity and Pregnancy 
Ovesen et al. showed that in a cohort of Danish women who had singleton pregnancies 
from 2004-2010 (a total of 369,347 women), those who were considered overweight or obese had 
significantly increased risks of several adverse pregnancy outcomes. These outcomes included 
those that affected the mother, the delivery, and the neonate. Outcomes primarily affecting the 
mother included hemorrhage, gestational diabetes mellitus (GDM), thrombosis, and preeclampsia. 
Those that affected the delivery included planned or emergency Cesarean section, or shoulder 
dystocia with vaginal delivery; those that primarily affected the neonate included macrosomia 
(defined as weighing >4500g), low Apgar score, and stillbirth (Ovesen et al., 2011).  Appendix A 
illustrates their findings of how increased BMI increases the risk of the aforementioned pregnancy 
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outcomes. In summary, they found a significant association between maternal weight and each of 
these outcomes and identified that the odds of the adverse outcomes increased with increasing 
maternal weight.  
2.3.1 Gestational Diabetes Mellitus 
Gestational diabetes mellitus occurs when a woman develops insulin resistance and 
inadequate insulin secretion for the first time during pregnancy (ACOG, 2017).  Maternal insulin 
is known to be the primary growth hormone responsible for fetal development (Usta et al., 2017).  
Because women with GDM subsequently pass more glucose to the fetus than normal, the risk for 
fetal macrosomia is increased. This complicates pregnancies by putting women at risk for labor 
difficulties, necessitating a cesarean delivery, hemorrhage, or severe tears to the vagina. The 
prevalence of GDM in the United States is estimated at 5.6% (Deputy et al., 2018); with the 
prevalence being average in Pennsylvania (5.5%) and elevated in West Virginia (7.2%) (Deputy 
et al., 2018). 
Some women are at an increased risk of developing GDM, including those who had GDM 
in a previous pregnancy, have high blood pressure, are of certain ethnicities, or are overweight or 
obese (ACOG, 2017; Sommer et al., 2014).  Developing GDM also increases a woman’s risk to 
develop hypertension and preeclampsia. Women who develop GDM are at an increased risk to 
develop type II diabetes later in life (Sommer et al., 2014; Stubert et al., 2018).   
In addition to macrosomia, babies born to women with GDM are at an increased risk to 
have breathing problems, jaundice, low blood sugar at birth, as well as an increased risk of being 
overweight, obese, and developing diabetes in childhood (ACOG, 2017).   
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2.3.2 Preeclampsia 
Preeclampsia is a condition that occurs secondary to chronic hypertension during a 
pregnancy, typically in the third trimester. It is characterized by signs of organ failure secondary 
to hypertension, including proteinuria, low platelet count, abnormal kidney and/or liver function, 
pain in the upper abdomen, vision changes, fluid in the lungs, or severe headaches (ACOG, 2019).  
Women who are at a moderate to high risk for preeclampsia include those who have previously 
had preeclampsia, have diabetes mellitus, or other conditions such as hypertension, kidney disease, 
and autoimmune conditions, those who are African American, over 35 years of age, are pregnant 
for the first time, or have a body mass index over 30 (ACOG, 2019).  If a woman experiences 
preeclampsia, it may mean that the fetus needs to be delivered preterm, which poses risks to the 
baby including mortality. In addition, women with preeclampsia have an increased risk of 
developing cardiovascular and/or kidney disease later in life (especially those who deliver a 
preterm baby). Preeclampsia can also lead to eclampsia (seizures) and HELLP syndrome, a 
medical emergency characterized by hemolysis, elevated liver enzymes, low platelet count, and an 
increased risk of hepatic internal bleeding (ACOG, 2019).  
2.3.3 Pregnancy Loss 
Pregnancy loss, by miscarriage (20 weeks gestation or fewer) or intrauterine fetal death 
(more than 22 weeks gestation) are risks that have an increased association with maternal 
overweight during pregnancy. Miscarriage occurs at an increased rate in women who are obese 
compared with those who are of normal weight; additionally, recurrent miscarriage has been 
shown to be more common in obese women than in women of normal weight (Stubert et al., 2018).  
  12 
Stubert et al. continue that there is an increased prevalence of intrauterine fetal death (IUFD) in 
obese women compared to normal-weight women, caused by abnormal function of the placenta 
combined with arterial hypertension (Stubert et al., 2018).  Liu et al. found that when mothers were 
overweight or obese, infants had a higher risk of still birth  (OR 1.27, 1.81 respectively, 95% CI) 
(Liu et al., 2016). Further, Yao et al. found that maternal obesity was associated with 
approximately 25% of stillbirth between 37 and 42 weeks gestation (Yao et al., 2014).  
2.3.4 Preterm Birth 
Preterm birth – both spontaneous and medically indicated – has a higher prevalence among 
obese mothers and contributes to unfavorable neonatal outcomes. In a study of 12,950 deliveries, 
obese and overweight women were at an increased risk to have a large-for-gestational-age (LGA) 
delivery compared with normal BMI women in the study (Ehrenberg et al., 2004), demonstrating 
that each risk factor contributes independently to the risk of a macrosomic infant.  
2.3.5 Macrosomia 
Macrosomia occurs when there is excessive fetal weight gain (typically defined as 
weighing more than 4000-4500 grams). The prevalence of fetal macrosomia varies among ethnic 
groups, but occurs in approximately 6-10% of all newborns worldwide (Usta et al., 2017) and is 
estimated at 7% in the United States (Martin et al., 2018).  Women who experience excessive 
gestational weight gain or are obese are more likely to deliver a macrosomic baby (Stubert et al., 
2018).  As previously noted, hyperglycemia associated with GDM can lead to fetal macrosomia. 
Macrosomia is also more likely in pregnancies where women have a higher pre-pregnancy BMI 
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(Agudelo-Espitia et al., n.d.).  Fetal macrosomia, maternal obesity, and excessive weight gain 
during pregnancy are associated with childhood-onset obesity. Women who give birth to 
macrosomic babies are at an increased risk of infection, postpartum hemorrhage, prolonged labor, 
high degree perineal tears, anesthetic accidents, and thromboembolic events (Usta et al., 2017), 
and macrosomic fetuses are at higher risk of birth complications and/or defects, including perinatal 
asphyxia, meconium aspiration, clavicular fracture, brachial plexus injury, and shoulder dystocia 
(Chatfield, 2001).  Children who were macrosomic-at-birth are also at increased risk to develop 
hypertension, obesity, and type II diabetes mellitus (Usta et al., 2017).  Though maternal 
gestational diabetes is a risk factor for macrosomia, the majority of macrosomic fetuses are born 
to women without gestational diabetes mellitus and further, no identifiable risk factors for 
macrosomia (Usta et al., 2017).  There is no known utility to dietary restriction during pregnancy 
for its effect on fetal macrosomia (Chatfield, 2001).   
2.3.6 Shoulder Dystocia 
Shoulder dystocia is a delivery complication that occurs when the baby’s shoulders become 
lodged in the pelvis as a result of being proportionately too large for the birth canal. This 
complication is twice as likely to occur when maternal BMI is greater than 35 (Ovesen et al., 2011)  
Shoulder dystocia is likely a downstream effect of the culmination of other risk factors, including 
gestational diabetes, gestational age, and macrosomia.  Shoulder dystocia increases the risk of 
maternal postpartum hemorrhage, vaginal lacerations, anal tears, and uterine rupture (Ovesen et 
al., 2011).  
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2.3.7 Cesarean Delivery 
Cesarean delivery procedures are performed over 1 million times each year in the United 
States (Yuan et al., 2016).  Though it is a common procedure that reduces risk of maternal and 
fetal mortality there are risks associated with cesarean delivery. Maternal risks include infection, 
hemorrhage (Keag et al., 2018), an increased risk of mortality, 5-fold increased risk of cardiac 
arrest, 3-fold risk of hysterectomy and puerperal infection, and 2-fold risk of thromboembolism 
(Yuan et al., 2016).  Pregnancy after a cesarean delivery is associated with an increased risk of 
miscarriage, stillbirth, placenta previa, placenta accrete, and placental abruption (Keag et al., 
2018).  Compared to children born via vaginal delivery, children delivered via cesarean delivery 
experience respiratory complications at an increased frequency, including asthma, childhood 
wheeze, dermatitis and allergy (Keag et al., 2018; Yuan et al., 2016); these children also experience 
higher rates of other adverse health events throughout childhood and later in life (Yuan et al., 
2016).  A 2016 meta-analysis of a large cohort consisting of over 22,000 individuals found that 
cesarean birth was associated with a higher risk of obesity (Yuan et al., 2016).  Further, analysis 
of siblings in the study who were born by discordant modes of delivery (cesarean or vaginal) found 
that the odds of obesity were 64% higher for individuals born by cesarean delivery versus their 
siblings born by vaginal delivery (Yuan et al., 2016).  A 2018 meta-analysis found that cesarean 
delivery was associated with an increased odds of childhood obesity continuing throughout 
childhood up to early adulthood (Keag et al., 2018).   
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2.3.8 Birth Injury 
A population-based study from the Swedish Medical Birth Registry found that maternal 
BMI was associated with adverse neonatal outcomes (Blomberg, 2013).  The authors discuss that 
admission to a neonatal intensive care unit is based on regional clinical guidelines and therefore 
not standard, however, review of the literature and findings from their own population study 
indicated that morbid obesity in mothers conferred a significantly increased risk for many and 
varied adverse neonatal outcomes, which all require NICU admission for treatment (Blomberg, 
2013).  Table 3 lists these adverse outcomes based on information from the Swedish Medical Birth 
Registry from 1998-2008.  
Table 3: Birth Injuries and Maternal Morbid Obesity in Sweden 
Birth Injuries Strongly Associated with Maternal Morbid Obesity in Sweden 
Central Nervous System Peripheral Nervous 
System 
Skeletal  Other 
Intracranial laceration 
subdural hemorrhage 
cerebral hemorrhage 
intraventricular 
hemorrhage 
subarachnoid hemorrhage 
cerebral edema 
brain damage 
cranial nerve/ spinal cord 
injury 
Erb paralysis 
Klumpke paralysis 
Phrenic nerve paralysis 
Brachial plexus nerve 
injuries 
Fracture to skull, 
femur, other long 
bones, clavicle, etc.  
Birth asphyxia 
Aspiration 
syndromes/ 
pulmonary 
hemorrhage 
Bacterial 
sepsis of the 
newborn 
Convulsions 
of the newborn 
Feeding 
problems 
hypoglycemia 
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2.4 Influence of Maternal Weight on Clinical Genetics Studies 
The ability of noninvasive prenatal testing (NIPT) to detect fetal trisomic chromosomes 
relies on the proportion of fetal DNA (fetal fraction) present in a sample of maternal plasma. If 
fetal fraction is below 4%, NIPT cannot provide a result as to the detection of a fetal trisomy. 
Studies show that fetal fraction is significantly associated with maternal weight, such that fetal 
fraction decreases with increasing maternal weight (Ashoor et al., 2013; Stubert et al., 2018).  
Figure 2 illustrates findings from a 2013 study by Ashoor et al. which found that increased 
maternal weight decreased fetal fraction during a critical time period for genetics studies.  
 
Figure 2: Influence of Maternal Weight on Fetal Fraction 
 
This study found that the greatest contribution of fetal fraction was provided by maternal 
weight (Ashoor et al., 2013).  Assessment at 11-13 weeks of gestation is ideal for detection of 
aneuploidies in genetics, but also for predicting many pregnancy complications including preterm 
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birth, preeclampsia, and fetal growth restriction. This study found that the greatest contribution to 
fetal fraction was provided by maternal weight.  
Obese women have a higher rate of miscarriage with normal chromosome studies (euploid 
miscarriage). A 2014 study by Boots et al. investigated whether there was a significantly increased 
frequency of euploid miscarriage in obese women with recurrent early pregnancy loss (REPL). 
372 women with REPL (578 miscarriages) were included in the study; REPL was defined as two 
or more pregnancy losses at less than 10 weeks of gestation, and at least one ultrasound-
documented miscarriage with chromosome results was required. The findings from this study 
showed that 58% of obese women’s miscarriages were euploid, while 37% of nonobese women’s 
miscarriages were euploid (Boots et al., 2014).  Further, the two groups (obese and nonobese) did 
not significantly differ in the frequency of endocrine factors, autoimmune factors, or endometritis 
(Boots et al., 2014), eliminating possible confounding factors in this analysis.  This study indicates 
that maternal obesity may be a risk factor for early pregnancy loss regardless of chromosome 
abnormalities in the fetus, especially with a history of miscarriage.  
Diabetes and hyperglycemia are risk factors for neural tube defects (NTDs) (Racusin et al., 
2012).  NTDs also show dose dependence, where maternal overweight is a risk factor for neural 
tube defects and obesity is a risk factor specifically for spina bifida and anencephaly (OR for NTDs 
in obese women: 1.85, 95% CI (Racusin et al., 2012)).   
2.5 Influence of Maternal Weight on Childhood Health 
Obese pregnant women are at increased risk of adverse health outcomes such as gestational 
diabetes and preeclampsia.  Their offspring are at increased risk for birth defects, macrosomia, and 
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morbidity associated with subsequent childhood obesity (Kabiru & Raynor, 2004; Madsen et al., 
2012).  Development of human primary dentition begins at the end of the fifth week of gestation 
(Ntani et al., 2015). Timing of primary incisor eruption has been shown to have a strong heritability 
of over 70% (Ntani et al., 2015).  Various processes can occur during critical periods of fetal 
development that can result in lifelong effects on health; many factors associated with advanced 
dental development are also associated with primary dentition dental caries (Ntani et al., 2015).  
Regardless of pre-pregnancy BMI, it has been reported that up to 62% of pregnant women have 
an excess in gestational weight gain (Durie et al., 2011).  This excess weight gain has been shown 
to have implications for maternal health, neonatal health, as well as continued health of the child.  
2.5.1 Birth Defects 
Maternal BMI has previously been shown to be associated with other adverse health 
outcomes in children.  One example is illustrated in a study of congenital heart defects.  Of infants 
born between 1992 and 2007 in Washington, U.S.A., 14,142 were identified as having a congenital 
heart defect (CHD).  After excluding those with a known chromosome abnormality or those whose 
mothers had diabetes mellitus, birth records from these infants found that those born with CHD 
were more likely to have an obese mother (Odds ratio: 1.22, 95% CI: 1.15-1.30); and furthermore, 
this association was found to increase with increasing maternal BMI (Madsen et al., 2012). This 
finding was replicated by the Atlanta Birth Defects Risk Factor Surveillance Study which reproted 
that pregnancy BMI was an independent risk factor for congenital heart defects (Racusin et al., 
2012). Evidence from these studies implicates obesity as a teratogenic factor in a developing 
pregnancy.   
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Similarly, the Pregnancy Health Interview Study (Slone Birth Defects Study) indicates a 
relationship between maternal weight and neural tube defects.  Mothers with high dietary glycemic 
index (DGI) or dietary glycemic load (DGL) have been shown to have a 1.5 and 1.9 times greater 
odds, respectively, of having a pregnancy complicated by a neural tube defect (NTD) (Yazdy et 
al., 2010).  These results implicate maternal obesity and/or diabetes as risk factors for neural tube 
defects.  One hypothesis for this phenomenon is that, in the setting of hyperglycemia, there is an 
increased rate of apoptosis in neural tube cells of the growing fetus, leading to a neural tube defect 
(Madsen et al., 2012).  Longitudinal and cross-sectional population-based data indicate that a 
higher BMI is correlated with lower serum folate levels, regardless of folate intake.  Since the 
1990s, folate supplementation has not been shown to reduce the incidence of NTDs in fetuses of 
obese women (Racusin et al., 2012).  
2.5.2 Higher Birth Weight and its Associated Childhood Morbidities 
Tyrrell et al. (2016) studied data from newborns in the Early Growth Genetics Consortium 
to determine whether there was genetic evidence of a causal relationship between maternal BMI 
and birth complications.  They studied maternal risk factors hypothesized to increase fetal growth 
including BMI, fasting glucose level, gestational or type II diabetes, triglyceride level, high-
density lipoprotein cholesterol (HDL-C) level, and adiponection level.  Additionally, they 
analzyed maternal factors hypothesized to decrease fetal growth including hypertension and lower 
vitamin D levels.  Single-nucleotide polymorphisms were selected to represent each trait based on 
previous evidence (Tyrrell et al., 2016) to create a weighted genetic score for the maternal traits, 
which was analyzed for association with birth weight and neonatal leanness.  Overall, higher birth 
weight and ponderal index (lower neonatal leanness) had significant associations with maternal 
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BMI, fasting glucose, and type II diabetes genetic scores (Tyrrell et al., 2016).  The results from 
this study indicate that there is evidence for a causal relationship between maternal glucose levels 
(glycemia) and higher birth weight via increased placental glucose transfer and fetal insulin 
secretion (Tyrrell et al., 2016).  It is important to consider these results as they represent a complex 
multifactorial link between maternal genetic risk scores for a pregnancy outcome of higher birth 
weight.  
A systematic review by Falvigne et al. reported that treatment of GDM was effective in 
reducing the rates of macrosomia, preeclampsia, and shoulder dystocia.  The risk of fetal 
macrosomia should be considered during prenatal care for pregnant women with pre-gestational 
or gestational diabetes mellitus.  In this study, maternal age parity, pre-pregnancy BMI, and 
gestational weight gain of mothers were significantly higher in mothers of macrosomic infants 
than in controls.  Additionally, rates of cesarean deliveries were significantly higher, and maternal 
age over 35 years tripled the risk of fetal macrosomia (Usta et al., 2017).   
The finding that macrosomia is associated with earlier eruption of primary teeth is 
consistent across many studies and populations (Delgado et al., 1975; Warren et al., 2016; Wu et 
al., 2019).  A 2019 study by Wu et al. analyzed 1296 Chinese mothers aged 20 to 41 in their first 
trimester of pregnancy.  They found that 5.23% (58 of 524) infants had macrosomia, defined as 
weighing more than 4000g at birth.  Macrosomia was found to be significantly associated with 
earlier eruption timing of the first primary tooth (ETFPT) (Wu et al., 2019).  Macrosomic-at-birth 
infants, on average, had their first tooth eruption at 5.91 months of age, which was significnatly 
lower than the 6.82 months for the mean of all infants in the study.  This is consistent with findings 
that higher birth weight is associated with earlier tooth emergence, and prematurity and low birth 
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weight seem to be associated with delayed tooth emergence (Delgado et al., 1975; Warren et al., 
2016).   
Similarly, Garmash et al (2019) found that the highest burden of (dental) caries were 
recorded in children who were macrosomic-at-birth with well-balanced intrauterine development, 
with intrauterine obesity and increased body length, or with intrauterine obesity and average body 
length.  Additionally, they found that children born with fetal macrosomia had long narrow faces 
and high palates more frequently than normosomic-at-birth children from their study (Garmash 
2019).  
2.6 Lifestyle Considerations 
It is important to note that the relationship proposed here between maternal BMI, infantile 
macrosomia, and childhood morbidities such as obesity and early tooth eruption should not be 
considered linear. Most likely these conditions are enmeshed with other risk factors for poorer oral 
health outcomes in children.  Studies have shown that maternal lifestyle and socioeconomic risk 
factors – notably obesity and smoking – are associated with poorer dental health in children, 
including increased rates of caries development in both primary and permanent teeth (Julihn et al., 
2009).  A link between childhood obesity and dental caries has been described in the literature, but 
little is known about any relationship between maternal (over)weight and dental caries in children.  
One hypothesis is that maternal overweight, via overnutrition during prenatal and perinatal 
development, has long-term effects on children – specifically, their continued eating habits and 
appetite regulation have impact on caries development (Julihn et al., 2009).    
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2.7  Tooth Eruption 
Tooth eruption in children is a tightly regulated process that involves physiological 
interactions within the oral cavity as well as a genetic element of regulation (Carolina Un Lam et 
al., 2016).  Primary tooth formation and eruption are both sequentially controlled and require 
interactions pre- and postnatally. Tooth eruption demonstrates a relatively high (at least 70%) 
heritability (Carolina Un Lam et al., 2016) and so variation in the timing of tooth eruption outside 
of genetic influence appears multifactorial and is not as well understood.  When there are 
disturbances to the patterns of tooth formation and/or eruption, there are several possible 
etiologies: physical/structural pathologies include dental follicle, root, and alveolar bone; systemic 
pathologies include aberrations of cellular, molecular, and/or genetic origin (Carolina Un Lam et 
al., 2016).   
At the molecular level, the dental follicle and parathyroid hormone-related protein regulate 
metabolic changes in the alveolar bone to stimulate tooth eruption (Declerck et al., 2007).  
Overweight and obesity in childhood have been associated with early eruption of primary teeth, as 
has childhood diabetes mellitus – suggesting the importance of metabolic processes on the timing 
of tooth eruption.  Because these processes happen simultaneously, it is likely that prenatal, 
perinatal, and postnatal factors all have an inter-related influence on the timing of a child’s first 
tooth eruption.  
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3.0 Manuscript 
3.1 Background 
Increased body mass index during pregnancy is a risk factor for adverse maternal (Kabiru 
& Raynor, 2004; Stubert et al., 2018) and fetal (Ehrenberg et al., 2004; Stubert et al., 2018; Yao 
et al., 2014) outcomes.  Children born to overweight or obese mothers can experience higher rates 
of congenital birth defects (Madsen et al., 2012; Racusin et al., 2012; Yazdy et al., 2010) and/or 
adverse health outcomes later in childhood (Julihn et al., 2009; Keag et al., 2018). Obesity is a 
complex disease of public health importance that affects pregnancy (Keag et al., 2018; Stubert et 
al., 2018) and can be onset in childhood.  Childhood onset obesity is associated with other 
childhood comorbidities, including juvenile diabetes, earlier tooth eruption, and poorer dental 
health outcomes (Delgado et al., 1975; Garmash, 2019; Ntani et al., 2015; Warren et al., 2016; 
Yuan et al., 2016).  The population in rural Appalachia represents a uinque subset of the United 
States that is subject to higher rates of adverse health outcomes due to being historically isolated 
geographically, as well as sociodemographically disadvantaged (Neiswanger et al., 2015).   
The current study will further the current understanding of the relationship between BMI 
and pregnancy outcomes, including childhood health, in Appalachia.  The study uses a subset of 
data gathered from women and children participating in the University of Pittsburgh and West 
Virginia University’s longitudinal research study, COHRA2: Factors Affecting Oral Health in 
Disparities in Appalachia.   
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3.1.1 COHRA2: Factors Affecting Oral Health Disparities in Appalachia  
The Center for Oral Health Research in Appalachia (COHRA) study, Factors Affecting 
Oral Health Disparities in Appalachia, is a longitudinal study aiming to identify genetic, microbial, 
and environmental determinants of oral health in northern Appalachia (Neiswanger et al., 2015).  
The study enrolls pregnant women to follow over the course of their pregnancy and child’s 
development.  Data are collected on mothers’ general and oral health, households’ and individuals’ 
environments, and infants’ general and oral health (Neiswanger et al., 2015).  During study visits, 
participants provide answers to surveys about their health, participate in dental assessments, and 
provide saliva samples for microbial analysis and DNA extraction.  The data used for the following 
analyses were obtained from the surveys and measurements taken at participants’ COHRA2 study 
visits.    
Over the course of time, participants in the COHRA2 study have provided information 
relevant to their child’s growth and development.  Now that the study has completed visits through 
age two for all mother-child pairs in the initial (Caucasian women) arm of the study,  it is pertinent 
to assess data on childhood growth and development in the first two years of life.  We now have 
enough data to compare our study population to the trends observed throughout the United States 
and other parts of the world, i.e., to assess whether the population of Appalachia – who are being 
assessed for risk factors for general and oral health outcomes – are also a population that has higher 
risks associated with pregnancies.   
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3.1.2 Eligibility Criteria 
Women were eligibile for enrollment in COHRA2 if they lived in the United States, and 
were Caucasian, generally healthy, English-speaking, not infected with tuberculosis or 
immunocompromised, and were pregnant.  Singleton pregnancies less than 29 weeks gestation 
were eligible for enrollment in the study. 
3.1.3 Study Aim 
The goal of this study is to assess whether there is a significant relationship between 
maternal weight and adverse maternal, neonatal, or childhood health outcomes.  The specific aims 
for the study are as follows.  
3.1.3.1 Specific Aims 
1. Obtain a data set of mother-child pairs participating in the COHRA2 study to define as the 
study cohort.  
2. Obtain, from a set timepoint in the exisiting dataset, BMI measurements, maternal health 
information, birth measurements, and early childhood health information to define 
variables for study, along with basic demographic variables.  
3. Define relationships between maternal BMI and dependent variables of interest; analyze 
whether there is a significant relationship between BMI and any of the cited risk factors in 
the COHRA2 participants.   
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4. Identify statistically significant demographic differences between cohorts from West 
Virginia and Pennsylvania to comment on sociodemographic differences in the study 
cohort.  
3.2 Methods 
3.2.1 Institutional Review Board  
The COHRA2 study has been approved by the University of Pittsburgh and the West 
Virginia University IRBs. Written informed consent was obtained prior to beginning any research 
procedures. This study used data from the COHRA2 study, and no additional IRB approval was 
required.  
3.2.2 Data Collection 
Data were collected from participants during study visits and included a mix of self-
reported information and measurements taken by a research coordinator.  The visits occurred at 
set time points and were recorded via SNAP online surveys.  For this study, information was 
selected from several different visits.  Information about mothers was obtained from the initial 
study visit, also known as the prenatal visit.  Pregnancy body mass index was calculated using 
mothers’ weights and heights measured at the prenatal study visits, and gestational age calculated 
by their reported due dates.  Using recommendations from professional obstetric guidelines 
(Government of Canada, 2014; Institute of Medicine (US) and National Research Council (US) 
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Committee to Reexamine IOM Pregnancy Weight Guidelines, 2009), high BMI alone is a risk 
factor at any point in pregnancy and this study did not control for gestational age in determining 
whether it influenced BMI. Due to lack of data on rates of weight gain by trimester that are 
representataive of the U.S. population (Institute of Medicine (US) Committee on Nutritional Status 
During Pregnancy and Lactation, 1990), we did not adjust for gestational age in determining BMI 
status.  
Information about pregnancy complications, labor, delivery, and newborn biometrics 
(length, weight, and head circumference) were obtained from the birth visit or first postnatal visit. 
Data on childhood growth parameters (height and weight) were obtained at one, two, and three-
year visits. 
In Pittsburgh, a participant’s fourth visit occurs 2-3 weeks after the child’s first primary 
tooth erupts, rather than at a set time point for a child’s age. Approximate ages of children at the 
time of first primary tooth eruption were obtained from phone interview and visit records.  
3.2.3 Data Categorization and Cleaning 
The Institution of Medicine’s guidelines for healthy weight gain during pregnancy are 
outlined in a chart of suggested weight gain per week of gestation (see Table 1).  This chart was 
used to categorize whether women were within a healthy weight category at the time they entered 
the study. Using this chart, women were categorized into one of four BMI categories: BMI 1 were 
below the recommended range (less than 18.5), BMI 2 were within the recommended range (18.5-
24.9), BMI 3 were in the overweight range (25.0 – 29.9), and women in BMI 4 were obese (30.0 
or greater).  
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Mother-child pairs were excluded from the study if there was not a pregnancy BMI or 
weight available for the mother, the baby was born prematurely, or if measurements for baby’s 
birth height and weight were unavailable.  
Infants were classified as macrosomic-at-birth if they weighed at least 4.00 kilograms.  
Children’s weight was classified at subsequent visits.  The CDC’s National Center for Health 
Statistics Data Tables for Girls or Boys Weight-for-length charts were used to identify the 
percentile for growth of each child at their one, two, and three-year visits.  Children identified as 
being at or above the 95th percentile for growth were classified as obese (Centers for Disease 
Control and Prevention National Center for Health Statistics, 2019).  
3.2.4 Data Analysis 
Data were visualized and tested using Microsoft Excel.  For all tests, a significance level 
of α=0.05 was set.  A two-tailed Z-test was utilized to compare the proportions of mothers in each 
BMI category by site, such that any statistical significance in a proportion of women in one BMI 
category at a given site could be identified.  
The prevalence of pregnancy obesity in our study sample was compared to the general 
population of the United States.  A 2018 meta-analysis of maternal obesity by Chen et al. utilized 
free-access databases from the World Health Organization to determine the rate of obesity in 
pregnancy and the approximate number of obese pregnant women at any given time. Their 
methods determined that the rate of obesity in pregnancy in the United States is 34.9% (Chen et 
al., 2018).  This proportion was used as a comparison in a one proportion Z-test to determine the 
significance of obesity prevalence in our study sample.  
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Prevalence statistics reported by the CDC (Deputy et al., 2018) were used to compare the 
occurrence of gestational diabetes mellitus in our sample to that in the general population.  A one-
proportion Z-test was utilized to identify whether there was statistically significant difference in 
prevalence.  
The proportion of Cesarean deliveries performed was compared two ways: the proportion 
of West Virginia mothers versus Pittsburgh mothers who had Cesarean deliveries, and the 
proportion of normosomic versus macrosomic infants delivered via Cesarean.  Both comparisons 
were performed using two-tailed Z-tests to analyze proportions.   
The proportion of macrosomic infants born to women in each BMI category was compared 
to the collective proportion of macrosomic infants born to women in the other three categories.  A 
two-tailed Z test to compare proportions was used to determine any significant differences.   
Pregnancies that resulted in a child with a congenital birth defect were analyzed for any 
pregnancy complications.  Children with identified genetic and/or syndromic conditions were 
excluded from the subset, such that the analysis only included children with a seemingly idiopathic 
congenital defect.  Retrospective analysis of the pregnancy complications was performed to 
identify any risk factors related to the birth defect, including preeclampsia, GDM, overweight or 
obesity, and preterm labor.  A chi-squared goodness-of-fit test was used to test for significant 
differences in the distribution of birth defects across BMI categories.  
3.3 Results 
Overall, there were 1009 participants enrolled in the COHRA2 study for whom data was 
available.  After excluding participants for whom data on pregnancy weight or birth weight of the 
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baby was not available, 995 mother-child pairs were defined as the study sample.  545 pairs 
(54.7%) were enrolled through the Pittsburgh study arm and 450 (45.3%) were enrolled through 
the West Virginia study arm.  532 babies were male (53.5%) and 462 were female (46.5%).   
BMI: Figure 3 shows the distribution of pregnant women in each BMI category by 
recruitment site (West Virginia or Pennsylvania).   
 
Figure 3: Distribution of Pregnancy BMI in Pittsburgh and West Virginia 
 
Most women were overweight or obese.  The overall rate of pregnancy obesity in our study 
sample (35.58%) was not higher than the general United States population (34.90%, p=0.65).  
There were no significant differences in the proportions of underweight (p=0.16) or normal weight 
(p=0.71) women enrolled at each site.  A significant increase was identified in the proportion of 
overweight women enrolled in Pittsburgh (p=1.41x10-6).  Likewise, a significant increase was 
identified in the proportion of obese women enrolled in the West Virginia site (p=2.19x10-5).  
Figure 4 summarizes the results from relationships tested in the study.  
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Figure 4: Relationships Between Maternal Obesity and Health Outcomes 
This figure demonstrates proposed relationships from the observations made in this study.  Maternal obesity 
was associated with an increase in macrosomia and Cesarean delivery.  Gestational diabetes occurred at an 
increased rate from the general population and was associated with higher rates of Cesarean deliveries.  
Macrosomia occurred at similar rates in obese women with or without GDM. Macrosomic children had earlier 
tooth eruption.  West Virginia study participants were more often obese, had more Cesarean deliveries, and 
had earlier tooth eruption. Rates of macrosomia and first tooth eruption may warrant further investigation 
into factors contributing to childhood obesity. 
 
Delivery: Mode of delivery was reported for 990 babies in the study.  Two hundred 
seventy-five babies were born via Cesarean delivery, comprising 27.78% of the study sample.  144 
babies in West Virginia (32%) and 131 babies (24%) in Pittsburgh were reported as being delivered 
by Cesarean section.  The difference in proportion of babies delivered via Cesarean was 
significantly different (p=0.005), wherein a greater proportion of West Virginian women had a 
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Cesarean delivery.  Figure 5 illustrates the proportion of Cesarean deliveries distributed across the 
four maternal BMI categories.  
 
Figure 5: Cesarean and Vaginal Deliveries in COHRA2  
 
There was a significant difference in the distribution of Cesarean deliveries across BMI 
categories (p=2.398x10-33).  No significant difference was found between the Cesarean delivery 
proportion for women in the “underweight” BMI category compared to the other three categories 
combined (p=0.96); and similarly, no significant difference was found between the proportions of 
babies born via Cesarean delivery in the “overweight” category compared to the proportion of 
Cesarean deliveries in the other categories (p=0.95).  However, significantly more Cesarean 
deliveries were found in the obese study sample (p=4.5x10-8) and significantly fewer for the 
normal weight study sample (p=6.25x10-9).   
Macrosomia: Figure 6 shows the proportion of macrosomic infants born to women in each 
BMI category at both West Virginia and Pittsburgh sites.   
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Figure 6: Normosomic and Macrosomic Infants Born to Women in Each BMI category  
 
One hundred (100) babies were classified as macrosomic, comprising 10.1% of the study 
sample.  There was no difference in the proportion of infants that were macrosomic between West 
Virginia (10.22%) and Pittsburgh (9.93%) (p=0.95).  No women who were in the underweight 
BMI category at either site gave birth to a macrosomic infant.  No significant difference was found 
between the macrosomia proportion for women in the “underweight” BMI category compared to 
the rest of the women (p=0.375); likewise, no significant relationship was found when comparing 
the macrosomia proportion in the normal BMI group to the other women (p=0.106).  A significant 
difference in the proportion of macrosomic infants born to women whose BMI was categorized as 
overweight was observed compared to the macrosomia proportion in other women (p=0.008) and 
the most significant difference was seen in the proportion of macrosomic infants born to obese 
women compared to other women (p=0.003).   
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Gestational Diabtes Mellitus: Eighty-one women in our study reported gestational diabetes 
mellitus (8.14%). A one-proportion Z-test revealed that this prevalence (8.1%) was different from 
the prevalence of gestational diabetes mellitus in caucasian women in the U.S. general population 
(5.3%, reported by Deputy et al. 2016) (p=6.34x10-5).   50 of 720 vaginal births were pregnancies 
complicated by GDM (6.94%).  A total of 31 out of 275 Cesarean births were complicated by 
GDM; a two tailed Z-test for proportions revealed a significant difference in proportions of women 
with GDM who eventually had a Cesarean delivery and those who had a vaginal delivery (p=0.03). 
Because there was a notable difference in the prevalence of GDM in our study, we repeated 
the prior test excluding women whose pregnancies were complicated by GDM.  The results 
showed that there was no signficant difference in the proportion of macrosomic infants born to 
obese mothers with or without GDM (p=0.98).   
Prenatal Risk Factors: Pregnancies resulting in Cesarean deliveries were assessed for 
prenatal risk factors.  The collection of risk factors are summarized below in Table 4.  Numbers 
that are highlighted represent categories in which the number of women who developed the 
condition exceeded the number of women who were identified as being at risk for the condition.  
Table 4: Reported Risk Factors in COHRA2 Pregnancies 
Risk Factor Number of Women Reporting 
Risk for High Blood Pressure Reported 
• Diagnosed in 1st Trimester 
• Diagnosed in 2nd Trimester 
• Diagnosed in 3rd Trimester 
75 
21 
27 
167 
7.5% 
2.1% 
2.7% 
16.8% 
Diabetes 45 4.5% 
Gestational Diabetes 
• Diagnosed in 1st Trimester 
• Diagnosed in 2nd Trimester 
• Diagnosed in 3rd Trimester 
33 
24 
26 
81 
3.3% 
2.4% 
2.6% 
8.1% 
Preeclampsia 64 6.4% 
Ruptured Membranes 0 0% 
Risk for Preterm Delivery 86 8.6% 
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Figure 7 illustrates observed risk factors in the study that resulted in 5 mother-child pairs 
experiencing three risk factors (GDM, Cesarean delivery, and macrosomia) for later adverse health 
outcomes. All five of these mothers were obese.  Of these five, two pregnancies were also 
complicated by a risk for preterm labor and one by hypertension and risk of preterm labor.  Of the 
33 Cesarean deliveries to macrosomic infants, three pregnancies were complicated by 
hypertension and risk of preterm labor.  
 
Figure 7: Overlapping Risk Factors Observed in COHRA2 Pregnancies 
 
Congenital Defects: Data on congenital birth defects was collected for newborns.  After 
excluding defects associated with genetic or syndromic conditions, 19 newborns were reported to 
have a congenital birth defect. (1.90% of the study sample).  While sample sizes were too small to 
perform statistical analyses with enough power, the distribution of birth defects across maternal 
BMI categories is displayed in Figure 8.  A list of the birth defects reported can be found in 
Appendix C.   
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Figure 8: Congenital Birth Defects Reported in COHRA2 
 
Fifteen infants had a congenital heart defect.  Of these 15 infants, only one had a mother 
that developed gestational diabetes mellitus during pregnancy (6.67%).  Six of the remaining 14 
infants were born to mothers with normal BMI; an additional 6 were born to overweight mothers, 
and 2 were born to obese mothers.  This distribution across BMI categories is not different than 
expected (p=0.36) given the BMI distribution of women in the study.  
Childhood Obesity: Thirty-five children that were macrosomic at birth were above the 95th 
percentile (obese) on CDC growth charts at their first birthday.  One-year data were unavailable 
for 16 macrosomic-at-birth infants, therefore this number represents 35.00% of macrosomic-at-
birth children and an overall 2.51% of children in the study sample.  Thirty-eight children that 
were macrosomic at birth were above the 95th percentile on growth charts at their second birthday.  
Twenty children who were macrosomic at birth were above the 95th percentile on growth charts at 
their third birthday.  
Underweight
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Tooth Eruption: Data were available on the time of first tooth eruption for 526 children 
from Pittsburgh and 312 children from West Virginia (838 children total).  The mean time to first 
tooth eruption in Pittsburgh was 32.64 weeks. The mean time to first tooth eruption in West 
Virginia was 27.47 weeks. A two-sample Z-test for means revealed a significant difference 
(p<0.0001).  The mean time to first tooth eruption in normosomic infants was 31.39 weeks, while 
the mean in macrosomic infants was 29.77 weeks.  Again, a two-sample Z-test for means revealed 
a significant difference (p=0.007).   
3.4 Discussion 
The results of this study show that more overweight women in Pittsburgh and more obese 
women in West Virginia are enrolled in COHRA2 study, comprising the majority of the study 
sample.  The majority of Pittsburgh mothers were overwieght, suggesting that there may be pre-
pregnancy differences in BMI between women from the two sites, which may be due to the 
socioeconomic differences (Neiswanger et al., 2015). The proportions of overweight women in 
Pittsburgh and obese women in West Virginia were equal (42%). Though the relationships tested 
in this study (and others (Bianchi et al., 2018; Ovesen et al., 2011; Sharp et al., 2017; Tyrrell et 
al., 2016; Usta et al., 2017)) indicate that obesity is a risk factor, the fact that 29% of women from 
Pittsburgh were obese should not be discounted.  Differences in mean gestational age at the time 
of measurement were not considered in this study and may have influenced why fewer women 
from Pittsburgh were classified as obese. Studies observed relationships indicating that there is a 
dose-dependant relationship between maternal weight and fetal outcomes (Ovesen et al., 2011; 
Racusin et al., 2012). The women who were overweight may still be at risk if the risk is due to 
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pregnancy weight gain, and these women should also be counseled about the risks associated with 
increased maternal weight during prengancy. 
West Virginia mothers had significantly more Cesarean deliveries than Pittsburgh mothers, 
and obese women from both sites combined for a significant majority of cesarean deliveries.  
Likewise, significantly more macrosomic infants were born to obese mothers.  Associations 
between maternal obesity and both Cesarean delivery and macrosomia are observed in our study 
sample, which is consistent with the previously published data (Keag et al., 2018; Ovesen et al., 
2011; Usta et al., 2017; Yuan et al., 2016).    
The increased rate of Cesarean deliveries in West Virginia is well-documented.  An 
initiative started in 2011 by the West Virginia Perinatal Partnership, West Virginia Chapter of the 
March of Dimes, the West Virginia Health Care Authority, and the West Virginia Health Statistics 
Center aimed to address the growing rate of Cesarean deliveries among nulliparous women.  Their 
research showed that 35.1% of nulliparous West Virginian women delivered via Cesarean in 2009  
(West Virginia Perinatal Partnership & March of Dimes, West Virgina Chapter, 2014).  The 
beginning of this initiataive coincided with the beginning of recruitment for COHRA2.  A yearly 
analysis or more recent data collection may find a smaller difference in the rate of Cesarean 
deliveries between these two sites, with West Virginia hospitals effecively implementing these 
interventions (West Virginia Perinatal Partnership & March of Dimes, West Virgina Chapter, 
2014).   
Of note, there was no significant difference in the number of macrosomic infants born in 
West Virginia and Pittsburgh.  Because of this, the difference in the rate at which Cesarean 
deliveries were performed is of interest.  We have previously discussed that there was a significant 
difference in the proportion of women from West Virginia that were obese. It is possible that the 
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women in the West Virginia arm of the study experienced more pregnancy complications that 
warranted Cesarean deliveries. Of course, it is also possible that there are differences in 
institutional threshold for performing Cesarean delivery.  Most women in the Pittsburgh arm of 
the study delivered their babies at Magee Womens Hospital of University of Pittsburgh Medical 
Center (UPMC).  Women in West Virginia are recruited from throughout the state and, as a group, 
may not have experienced access to a similarly standardized decision.  Reasons for Cesarean 
delivery also exist that were not captured in this data set, including (but not limited to) having had 
a Cesarean delivery with a previous pregnancy.   
We saw that there was a significant increase in the rate of Cesarean deliveries for women 
who experienced GDM.  Additionally, we observed that there was not a significant difference in 
the rate of Cesarean births between obese women who did or did not have GDM, implying that 
obesity is associated with Cesarean delivery whether or not the increase in BMI leads to GDM.  
The data from our study do not support an increased chance for congenital birth defects 
associated with maternal obesity.   Though literature supports an increased risk of congenital heart 
defects or spina bifida with increasing maternal weight, our study indicates that in this sample, 
birth defects are distributed evenly among maternal BMI classes.  There are several possible 
explanations for this difference.  First, it could be explained if the BMI distribution in our sample 
is significantly different from the general population of pregant women, which would give new 
defnition to the expected distribution of birth defects in each category if there were to be no 
difference from the general population.  It is also possible that women are underreporting birth 
defects in children or dropping out of the study prior to data collection due to health concerns for 
their children.  Third, this finding could be representing an underlying confounding factor that is 
modifying the risk for congenital birth defects in this population overall.  Finally, this result could 
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be an issue of statistical power.  We observed a total of 19 children with birth defects; samples that 
evaluate rates of birth defects often have much larger sample sizes to evaluate.  
Further, it is difficult to analyze the distribution of women by BMI category compared to 
the general population.  There is little literature identifying weight distribution of pregnant women 
in the general population.  Future studies that are designed to analyze maternal BMI or weight as 
a risk factor should consider collecting prepregnancy weight for women to accurately assess 
pregnancy weight gain and/or prepregnancy BMI.  Women in this study vary from 4-33 weeks 
gestation at their initial study visit, where BMI is assessed.  While pregnancy BMI and weight gain 
can be estimated from this cross-section, there is considerable margin for error in categorizing 
women based on pregnancy BMI when we do not have a way to obtain a measurement from every 
participant at the same time point – either prepregnancy or at the same gestational age.  The results 
found in this study are representatiave of the large sample of women in the study, but further study 
is warranted to determine whether these results are generalizable to women and children 
throughout rural Appalachia.   
In the Pregnancy, Infection, and Nutrition (PIN) Study at the Univesity of North Carolina 
Hospitals (UNC), women were recruited to study risk factors for preterm birth. This study 
identified that women who gained more than the recommended amount of weight were at increased 
risk for Cesarean delivery, high birth weight, macrosomia, and postpartum weight retention 
(Ferrari & Siega-Riz, 2013).  This study explored pregnancy weight gain in three different ways: 
(1) as a continuous variable of total pregnancy weight gain in kg, (2) as a ratio of observed to 
expected weigh gain, calculated by dividing the total weight gain in kg by the expected weight 
gain for gestational age, and (3) as a categorical variable of inadequate, adequate, or excessive 
weight gain (Ferrari & Siega-Riz, 2013).  Implementation of these methods to study pregnancy 
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weight gain would strengthen the maternal weight variable in our study. Many studies 
acknowledge that prepregnancy measurements are not feasible and that there is reasonable 
accuracy of a self-reported prepregnancy weight (Brunner Huber, 2007; Ferrari & Siega-Riz, 
2013). 
Two interesting findings from our study are the differences in time to first tooth eruption.  
Children from West Virginia had first tooth eruption significantly earlier than Pittsburgh children, 
and macrosomic children had first tooth eruption significantly earlier than normosomic children.  
We have already stated that there were significantly more obese mothers from West Virginia than 
from Pittsburgh.  This result comes in light of the finding that there was no significant difference 
in the rate of macrosomia between the two sites.  In concordance with the previously cited literature 
(Declerck et al., 2007; Tyrrell et al., 2016; C. Un Lam et al., 2017, 2017), we would expect that 
differences in macrosomia and differences in tooth eruption would be seen in the same study 
sample.  This necessitates further investigation into potential differences in risk factors for women 
and children in West Virginia that are not captured by this study.    
Strengths of this study include the size of the selected sample.  Women largely self-selected 
into the COHRA2 study based on the perception that they were generally healthy people.  In this 
way, we benefitted from obtaining a sample of women who consider themselves healthy from 
which to assess risk factors. The COHRA2 study is longitudinal and information was available 
about all study participants through at least the timepoint of a child’s third birthday.  Our study is 
able to assess risk factors that may impact individuals over time, versus assessing prevalence data 
from rural Appalachia at one point in time.  
The study’s main pitfall was that prepregnancy weights were not available for the women 
in the study.  Because COHRA studies enroll pregnant women and focus on childhood dental 
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health, prepregnancy weight is not a data point that is collected for women at their first visit.  Future 
studies would benefit from obtaining this data point for comparisons in order to assess whether 
there were any significant differences in the risk associated with prepregnancy overweight/obesity 
and increased pregnancy weight gain. The IOM advises that many studies of maternal determinants 
of pregnancy weight gain have used weight at the first visit to calculate BMI if the visit occurs 
prior to 16 weeks gestation, or by recalled prepregnancy weight (Institute of Medicine (US) 
Committee on Nutritional Status During Pregnancy and Lactation, 1990).  Future studies of this 
nature from COHRA2 participant data should use this gestational timeline as a parameter for 
defining the study sample. Alternatively, a logarithmic equation developed by the Argentinian 
Ministry of Health (see Appendix D) has been shown to effectively adjust maternal BMI for 
gestational age, though still requiring a prepregnancy weight for the function to categorize women 
by pregnancy BMI (Davies et al., 2013; Ministry of Health and Environment of the Nation, 
National Directorate of Maternal and Infant Health, 2017).   
Additionally, there is a potential that we have underrepresented congenital birth defects in 
our study. Data were available for participants who at least completed their third study visit, when 
babies are 10 weeks old.  Individuals who had more pregnancy complications or more severe birth 
defects may not have completed any follow-up study visits and therefore were not included in our 
data set.   
These results necessitate further study on risk factors for pregnancies in northern 
Appalachia.  Notable differences were present in Pittsburgh and West Virginia, which warrant 
further investigation.  We have identified important factors which may be determinants of 
childhood health outcomes beginning earlier than previously considered for this population.  A 
cohort study of U.S. women and children identified that maternal weight gain during pregnancy 
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was positively associated with prevalence of overweight children at 3 years of age (Li et al., 2019; 
Oken et al., 2009; Stamnes Køpp et al., 2012), which draws importance to our finding that 20% of 
macrosomic children were at or above the 95th percentile for growth at age three.  Additionally, Li 
et al. found that after adjusting for sex of the infant, maternal age, gestational weeks at birth, and 
gestational weeks when maternal weight was measured, there was still a positive association 
between both maternal pre-pregnancy BMI and weekly gestational weight gain with physical 
growth in  the child (Li et al., 2019).   
The COHRA studies also enroll African American women into the study.  African 
American women experience different health risks during pregnancy (ACOG, 2019).  
Additionally, African American women have the highest rate of obesity (57%) of all women in the 
U.S. and have a higher rate of weight retention and obesity after delivery compared to Cauasian 
women (Hales, 2017; Meng et al., 2018; Walker et al., 2011).  Lower rates of common birth defects 
are reported in African American children (Canfield et al., 2014). It is of interest to determine any 
differences or similarities observed when considering the two ethnic groups in the COHRA2 study 
sample, which may further define differences we have observed between West Virginia and 
Pittsburgh study subsets or identify important differences in health status.  
Another important finding that necessitates further investigation is the higher prevalence 
of diabetes in our study sample.  We also saw an increase in Cesarean deliveries in West Virginia.  
Reasons for this difference should be investigated to determine where and how to prevent adverse 
maternal and childhood health outcomes associated with Cesarean delivery.  
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3.5 Conclusions 
Overall, these findings bring imperative consideration to obesity as a disease phenotype.  
We see that even in the absence of other risk factors (i.e., diabetes), obesity is associated with 
increased rates of Cesarean deliveries and macrosomic infants.  Identifying that obesity is a risk 
factor is an important consideration for how to care for pregnant women.  Our findings illustrate 
that even when no other risk factors have been identified, children may have increased odds of 
being macrosomic and/or obese in childhood, or subject to earlier tooth eruption and subsequent 
childhood caries as a result of having an obese mother.  
The COHRA2 study sample also illustrates demographic differences that healthcare 
providers should consider.  For example, we saw significant differences in the presence of risk 
factors and adverse health outcomes such that West Virginia women were more likely to be obese 
and have Cesarean deliveries.  Additionally, children in West Virginia had an earlier time to first 
tooth eruption.  The implications of these significant differences in risk factors for further health 
problems may be helpful in designing effective public health interventions for this population.     
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4.0 Relevance to Genetic Counseling and Public Health 
Several important public health issues interact to increase the importance of investigating 
the current issues. The worldwide rate of overweight or obesity in adult women has increased from 
29.8% to 38% between 1980 and 2013 (Rahman et al., 2015).  Early childhood caries (ECC) has 
been reported to be the most common chronic disease in United States children. The data gathered 
during the COHRA2 study were uniquely situated to observe prevalence of risk factors in this 
population, and while the overarching study initiatives aim to identify factors contributing to oral 
health, we were able to identify some potential risk factors for early childhood health that begin in 
the prenatal setting.   
Geographic area is a contributing factor to both rising rates of obesity and primary tooth 
eruption.  Patterns of overweight and obesity differ between countries, regions, and income, such 
that obesity is more prevalent among men in developed countries and among women in developing 
countries (Ng et al., 2014; Rahman et al., 2015).  In 2013, the United States was home to the most 
obese individuals, accounting for 13% of the 693 million obese individuals worldwide (Ng et al., 
2014).  
In 2015, a meta-analysis of studies on risk factors related to maternal BMI in mothers from 
developing countries developed population-attributable risk (PAR) scores to evaluate the effect of 
geographical region/ sociocultural background on adverse pregnancy outcomes. This study found 
that overall, developing countries have a disease burden that is double that of developed countries 
for perinatal and maternal health outcomes that are attributable to maternal BMI (Rahman et al., 
2015).  Figure 9 shows the PAR scores that the study found to be the proportion of adverse 
outcomes related to maternal BMI by country.  
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Figure 9: Maternal BMI Associations with Disease Burden 
 
Rahman et al. also found an increased risk for preeclampsia, cesarean delivery, and post-
partum hemorrhage in women in overweight and obese categories compared with women in the 
normal BMI category (Rahman et al., 2015).  Further, these authors support that women in these 
lower-income countries should be counseled about optimal BMI prior to conception due to the 
lack of nutritional intervention and/or health care system support for interventions to prevent 
adverse outcomes from pregnancy (Rahman et al., 2015).  Additionally, distinct geographical 
patterns mark areas of increased child and adolescent obesity worldwide.  Higher rates of child 
and adolescent obesity are seen in Middle-Eastern countries, North Africa (primarily for girls), 
Pacific Islands, and Caribbean nations (Ng et al., 2014).  
Our findings suggest that women in northern Appalachia face similar risks for unhealthy 
BMI as women in other regions around the world.  Further, the children in our study – especially 
those in West Virginia – show signs of developing adverse health outcomes in relation to maternal 
BMI.  Pregnant women in this region would benefit from guidelines that support healthy weight 
gain during pregnancy based on pre-pregnancy BMI. The Maternal Obesity and Childhood 
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Outcomes (MOCO) consortium identified 50 European, North American, and Oceanian cohorts to 
develop international gestational weight gain charts for specific pre-pregnancy BMI categories, 
which will improve the risk assessment and risk reduction for pregnant women worldwide. Figure 
10 shows the MOCO 2018 guideline for healthy gestational weight (Santos et al., 2018).  
 
 
Figure 10 Maternal Obesity and Childhood Outcomes (MOCO) 
Selected percentiles of weight gain for gestational age in women without any pregnancy complication for 
maternal pre-pregnancy underweight(a), normal weight(b), overweight (c), obesity grade 1(d), obesity grade 
2(e), and obesity grade 3(F) 
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Evidence across generations and studies suggests that geographic region marks differences 
in the eruption timing of children’s primary teeth (Carolina Un Lam et al., 2016).  Even within the 
United States, the timing of tooth eruption varies between American Indian, Black, and White 
children (Warren et al., 2016).  Other ethnic groups – such as northern plains American Indians 
(Warren et al., 2016) – may experience a significantly different mean age of primary tooth 
eruption.  Individuals of Asian ethnicity have been shown to have significantly delayed tooth 
eruption when compared to white children (Ntani et al., 2015).  
4.1 Socioeconomics 
Socioeconomic factors are also important to consider.  Previous data show that prevalence 
of obesity is higher in rural areas than in urban areas (Chen et al., 2018).  Our data are consistent 
with this theory, as demonstrated by the disproportionate rate of obesity in West Virginia.  West 
Virginia, as we have previously stated, represents a region of the United States that is largely rural 
(it is the only state that is entirely located in Appalachia) and public health initiatives in the state 
largely focus on increasing access to health services.  
As shown in one study, children of mothers on welfare programs and/or living in more 
deprived areas are more likely to have advanced dental development (Ntani et al., 2015).  Children 
of taller and heavier mothers and mothers who had a poorer quality diet had earlier first tooth 
eruption, more teeth at one year of age, and were more likely to have advanced dental development, 
defined as more than 16 teeth at two years of age (Ntani et al., 2015).  These findings are consistent 
with the idea that individuals in lower socio-economic standing eat lower-cost foods which tend 
to have an increased sugar content, increasing the risk of dental caries development (Julihn et al., 
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2009).  Conversely, a study by Un Lam et al. found that intake of high-sugar foods was unrelated 
to early childhood caries at two years of age (C. Un Lam et al., 2017).  The same study found that 
Indian mothers consumed more cheese and yogurt – and therefore presumably had a higher 
calcium intake – than Chinese and Malay mothers in the study; additionally, the children in the 
study with Indian mothers experienced a lower caries rate than the other two ethnic groups (C. Un 
Lam et al., 2017).  They hypothesize that early childhood caries in toddlers are more associated 
with biological factors, and that plaque deposition is more affected by environmental or behavioral 
exposures in two-year-olds (C. Un Lam et al., 2017).   
4.2 Women Referred for Genetic Counseling 
We have shown that maternal weight is an important factor in assessing what will be a 
risky pregnancy.  Genetic counselors are specifically trained to support patients in obtaining 
information and resources that will promote health and well-being for families.  It is within reason 
for a genetic counselor to anticipate and assuage feelings of uncertainty or guilt surrounding risk 
information for patients.  The findings from our study may be useful to genetic counselors in 
advocating for patients by providing accurate risk in formation regarding BMI during pregnacy.   
Establishing the relationship between common (complex) disease phenotypes such as 
obesity or diabetes is important for future genetics studies in order to develop better clinical 
practices. Genome-wide association studies (GWAS) are a helpful tool for researchers to 
investigate the contribution of novel genes to complex disease phenotypes. Obesity is a complex 
disease phenotype with many factors, and diabetes mellitus is often a comorbidity of obesity. Both 
are known to have genetic components, and we have previously stated that both are known risk 
  50 
factors during pregnancy. It was previously known that there are multiple genes associated with 
type II diabetes. Recent studies have shown that several genes known to be associated with type II 
diabetes are also associated with gestational diabetes. Table 5 is adapted from Lowe Jr. and Karban 
(2014) and describes eight genetic loci known to be associated with both type II diabetes and 
gestational diabetes (Lowe Jr & Karban, 2014).   
Table 5: Genes Associated with Gestational Diabetes 
Genes with known associations with type II diabetes that demonstrate association with 
gestational diabetes.  
Gene Protein Function 
IRS1 Insulin receptor substrate 1 Substrate of insulin receptor tyrosine kinase 
IGF2BP2 Insulin-like growth factor 2 
mRNA-binding protein 2 
Binds insulin-like growth factor 2 mRNA and 
may regulate protein translation; risk allele 
associated with decreased insulin secretion 
CDKAL1 CDK5 regulatory subunit 
associated protein 1 like-1 
Unknown function 
GCK Glucokinase Phosphorylates glucose in pancreatic B-cells and 
hepatocytes and involved in the regulation of 
insulin secretion.  
TCF7L2 Transcription factor 7-like 2 Transcription factor and member of the Wnt 
signaling pathway. Risk allele associated with 
reduced insulin secretion. 
MTNR1B Melatonin receptor 1B G-protein coupled receptor that is expressed on 
B-cells, binds melatonin, and may antagonize 
insulin release 
KCNJ11 Potassium inwardly 
rectifying channel, subfamily 
J, member 11 
Integral membrane protein and inward-rectifier 
type potassium channel that is controlled by G-
proteins and associated with sulphonyl urea 
receptor; involved in regulation of insulin 
secretion 
KCNQ1 Potassium voltage-gated 
channel, KQT-like 
subfamily, member 1 
Voltage-gated potassium channel; involved in 
the regulation of insulin secretion 
 
Obesity risk genes that have been found to be involved in gestational weight gain include 
FTO, MC4R, TMEM18, and KCTD15 (Groth & Morrison-Beedy, 2015; Lawlor et al., 2011; 
Martins et al., 2016; Meng et al., 2018; Stuebe et al., 2010).  As more is understood about the role 
of genes in weight gain, it will be important to consider how this information becomes increasingly 
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relevant to clinicians who care for pregnant women who rapidly gain weight in a short amount of 
time.  
In the Pregnancy and Childhood Epigenetics (PACE) Consortium, Sharp et al. showed that 
BMI at the start of pregnancy was associated with differential methylation in newborn blood, such 
that children displayed epigenetic patterns associated with a higher risk of obesity and obesity-
related disorders later in life (Sharp et al., 2017).   
Considering the genetic components of these disease phenotypes will become increasingly 
important as we consider new genetic technologies and how they will impact patients.  While our 
study suggests that complex disease phenotypes may have a negative impact on a developing fetus, 
research on the genetics of these diseases may uncover new ways in which patients would benefit 
from genetic testing.  In the future, genetic counselors may be called to discuss how knowing a 
patient’s genetic risk of developing gestational diabetes could be beneficial to managing their 
pregnancy.    
Research shows that women who reported being advised about a healthy weight gain were 
more likely to gain within the recommended range than women who do not receive such guidance 
(Ferrari & Siega-Riz, 2013; Goswell et al., 1999; Stotland et al., 2005; S M Taffel & Keppel, 1986; 
Selma M. Taffel et al., 1993). In the UNC Hospitals PIN Study, 51.8% of women reported 
receiving weight gain advice by 27-30 weeks of pregnancy; there were no significant associations 
with whether or not women received advice based on race, age, marital stuatus, or prepregnancy 
BMI.  Ninety-one percent of these women reported following the advice, however, when 
controlling for hypothesized confounders and mediators, there was no evidence for an association 
between provider advice and pregnancy weight gain, and two thirds of women gained more than 
the IOM recommended weight during pregnancy (Ferrari & Siega-Riz, 2013).   
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Women who will be 35 years or older at delivery should be referred to a genetic counselor 
to discuss the increased risks for chromosomal aneuploidies in this population.  Wu et al. (2019) 
found a significantly earlier tooth eruption for children born to mothers over the age of 35 (Wu et 
al., 2019).  Previous findings show a relationship between maternal age and child growth 
parameters such that an increase in childbearng age was associated with taller stature in 
prepubescent children (Savage et al., 2013)  Similarly, other studies show that maternal age (>30 
years) is a risk factor for fetal macrosomia (Usta et al., 2017).  Sessions with genetic counselors in 
this population may elicit risk factors for later health implications in children.  As these 
relationships become better understood, it is worthwhile to provide genetic counselors with 
educational materials for their patients regarding the risks associated with increased weight during 
pregnancy.  Further, knowledge of these risk factors may help genetic counselors to counsel their 
patients in the presence of a negative test result for a genetic etiology for a known birth defect.   
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Appendix A Increased Maternal BMI and Adverse Pregnancy Outcomes  
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Appendix Figure 1: Adverse Pregnancy Outcomes Associated with Pregnancy BMI 
Figures are adaptations of results from Ovesen et al. 2011. 
 
Ovesen et al. found that there were significant differences in the risks for multiple adverse 
health outcomes if mothers were overweight or obese. The figures above illustrate the odds ratios 
found in their study. As these results show, there are increased odds of both adverse maternal 
outcomes and fetal outcomes. Gestational diabetes mellitus (B), emergency cesarean delivery (D), 
preeclampsia (E), low Apgar scores (F), macrosomia (G), and stillbirth (H) all showed dose 
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dependence, such that more obese women had higher odds of having adverse health outcomes 
compared with normal weight women (Ovesen et al., 2011).   
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Appendix B Obesity in Children That Were Macrosomic At Birth 
 
Appendix Figure 2: Weights of Children who were Macrosomic at Birth 
  57 
Children’s weights are shown in kilograms. Using the Centers for Disease Control and 
Prevention’s data tables for childhood length-for-weight, we determined which macrosomic 
infants in our study were obese (>95th percentile for growth) at their first, second, and third 
birthdays (in red).  These tables are standardized for male and female children. Some children were 
consistently obese throughout early childhood. Others normalized as they aged, and some 
alternated between overweight and obese. The negative number code (-9999) represents a time 
point at which data were not collected, most likely where the participant had discontinued from 
the study.  
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Appendix C Congenital Birth Defects Reported in COHRA2 Infants 
Appendix Table 1: Congenital Birth Defects Reported in COHRA2 Infants 
Congential Defect 
Reported 
Delivery Method Child’s Weight 
Category 
Mother’s BMI 
Category 
Heart murmur Vaginal Normosomic Overweight 
Heart murmur and 
spina bifida 
Cesarean Normosomic Overweight 
Heart murmur Cesarean Normosomic Obese 
Heart murmur and 
left-sided deafness 
Cesarean Normosomic Normal weight 
Heart murmur Cesarean Normosomic Overweight 
Heart murmur Vaginal Normosomic Nomal weight 
Heart murmur Vaginal Normosomic Normal weight 
Polydactyly and 
syndactyly 
Vaginal Normosomic Overweight 
Craniosynostosis Cesarean Normosomic Obese 
Ventral septal defect Vaginal Normosomic Overweight 
Heart murmur Vaginal Normosomic Overweight 
Patent ductus 
arteriosis 
Vaginal Normosomic Obese 
Heart murmur Vaginal Normosomic Overweight 
Heart murmur Vaginal Normosomic Normal weight 
Heart murmur Cesarean Normosomic Overweight 
Tetgralogy of fallot Vaginal Macrosomic Normal weight 
Heart murmur Cesarean Macrosomic Normal weight 
Craniosynostosis Vaginal Macrosomic Obese 
Polydactyly Vaginal Macrosomic Overweight 
 
This table lists the collective congenital birth defects reported in COHRA2 child 
participants that were determined to be isolated (not due to a genetic or syndromic condition). 
Additionally, information on each child’s mother’s body mass index, delivery method, and weight 
classification are shown. No significant relationships were identified in this study subset. Nineteen 
children were reported as having an isolated birth defect, representing 1.9% of the study sample. 
Further information on inclusion criteria for continuation in the COHRA2 study is needed to 
  59 
determine whether this percentage reflects the total number of children who were reported to have 
a birth defect. As such, the rate of birth defects in this study sample is not different from the general 
population (2-3%) and n is not large enough for any further comparisons.  
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Appendix D Equation for Determining Gestational BMI 
The following equation was developed by the Argentinian Ministry of Health to adjust 
maternal BMI for gestational age (GBMI = gestational BMI).  
If pregravid BMI is ≥ 21 to < 25 kg/m2, then the equation [(weight-5.5) / (height2)] = GBMI.  
GBMI can be categorized as follows:  
Appendix Table 2 Ministry of Health Gestational BMI Categories 
GBMI Category 
≥10 to ≤ 19.8 kg/m2 Underweight 
≥19.8 to ≤ 26.1 kg/m2 Normal Weight 
≥26.1 to ≤ 29 kg/m2 Overweight 
≥29 to ≤ 50 kg/m2 Obese 
 
(Davies et al., 2013; Ministry of Health and Environment of the Nation, National Directorate of Maternal 
and Infant Health, 2017).  
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